If approved by the EC, Tagrisso will be the first targeted therapy for European patients with unresectable EGFR-mutated cancer.
The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
The European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback